Zdrowie i gospodarka · 13/05/2015
FDA Clears Sulfacetamide Sodium Drug Products for Sale
The US Food and Drug Administration (FDA) has ruled that Sulfacetamide Sodium ophthalmic solution and ointment were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving Abbreviated New Drug Applications (ANDAs) for these products.